Ultragenyx Pharmaceutical’s Crysvita first FDA-approved medication for the treatment of XLH
The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical’s Crysvita (burosumab), the first drug approved to treat adults and children ages
Read more